Literature DB >> 20463314

Loss of tubedown expression as a contributing factor in the development of age-related retinopathy.

Robert L Gendron1, Nora V Laver, William V Good, Hans E Grossniklaus, Ewa Miskiewicz, Maria A Whelan, Jacqueline Walker, Hélène Paradis.   

Abstract

PURPOSE: Tubedown (Tbdn), a cortactin-binding acetyltransferase subunit, regulates retinal vascular permeability and homeostasis in adulthood. Here the authors explore whether Tbdn loss during aging might contribute to the mechanisms underlying age-related neovascular retinopathy.
METHODS: A conditional endothelial-specific transgenic model of Tbdn loss was compared with aged mouse and human specimens from 5- to 93-year-old individuals. Specimens were analyzed by morphometric measurements and for functional markers using immunohistochemistry and Western blot analysis.
RESULTS: An age-dependent decrease in Tbdn expression in endothelial cells of the posterior pole of the eye correlated with pathologic changes in choroidal and retinal tissues of aged mice. In humans, aged specimens without eye disease exhibited a moderate decrease in retinal and choroidal endothelial Tbdn expression compared with younger persons, whereas a greater decrease in choroid vascular Tbdn expression was observed in patients with age-related macular degeneration. In mice, Tbdn loss resulting from old age or conditional Tbdn knockdown was associated with retinal lesions showing significant extravascularly localized albumin and correlated with increased activity of senescence-associated β-galactosidase in the retinal pigment epithelium. A range of abnormalities in RPE, Bruch's membrane, and choriocapillaris observable at the ultrastructural level in Tbdn-knockdown eyes recapitulate those present in human AMD.
CONCLUSIONS: This work provides evidence that the marked decrease in the level of expression of Tbdn in the retinal and choroidal vasculature during aging contributes to the multifactorial process that leads to the development of age-related retinopathy and choroidopathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463314     DOI: 10.1167/iovs.09-4527

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

Review 1.  The biological functions of Naa10 - From amino-terminal acetylation to human disease.

Authors:  Max J Dörfel; Gholson J Lyon
Journal:  Gene       Date:  2015-05-16       Impact factor: 3.688

2.  Physiologic and molecular consequences of endothelial Bmpr2 mutation.

Authors:  Susan Majka; Moira Hagen; Thomas Blackwell; Julie Harral; Jennifer A Johnson; Robert Gendron; Helene Paradis; Daniel Crona; James E Loyd; Eva Nozik-Grayck; Kurt R Stenmark; James West
Journal:  Respir Res       Date:  2011-06-22

3.  Osmotic pressure-adaptive responses in the eye tissues of rainbow smelt (Osmerus mordax).

Authors:  Robert L Gendron; Elizabeth Armstrong; Hélène Paradis; Lacey Haines; Mariève Desjardins; Connie E Short; Kathy A Clow; William R Driedzic
Journal:  Mol Vis       Date:  2011-10-05       Impact factor: 2.367

4.  Tubedown regulation of retinal endothelial permeability signaling pathways.

Authors:  Nhu Ho; Robert L Gendron; Kindra Grozinger; Maria A Whelan; Emily Anne Hicks; Bimal Tennakoon; Danielle Gardiner; William V Good; Hélène Paradis
Journal:  Biol Open       Date:  2015-07-03       Impact factor: 2.422

5.  CD10+ Cells and IgM in Pathogen Response in Lumpfish (Cyclopterus lumpus) Eye Tissues.

Authors:  Robert L Gendron; Hélène Paradis; Raahyma Ahmad; Kenneth Kao; Danny Boyce; William V Good; Surendra Kumar; Ignacio Vasquez; Trung Cao; Ahmed Hossain; Setu Chakraborty; Katherinne Valderrama; Javier Santander
Journal:  Front Immunol       Date:  2020-11-20       Impact factor: 7.561

6.  Naa12 compensates for Naa10 in mice in the amino-terminal acetylation pathway.

Authors:  Hyae Yon Kweon; Mi-Ni Lee; Max Dorfel; Seungwoon Seo; Leah Gottlieb; Thomas PaPazyan; Nina McTiernan; Rasmus Ree; David Bolton; Andrew Garcia; Michael Flory; Jonathan Crain; Alison Sebold; Scott Lyons; Ahmed Ismail; Elaine Marchi; Seong-Keun Sonn; Se-Jin Jeong; Sejin Jeon; Shinyeong Ju; Simon J Conway; Taesoo Kim; Hyun-Seok Kim; Cheolju Lee; Tae-Young Roh; Thomas Arnesen; Ronen Marmorstein; Goo Taeg Oh; Gholson J Lyon
Journal:  Elife       Date:  2021-08-06       Impact factor: 8.713

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.